REQUEST A DEMO
Total
USD $0.00
Search more companies

Simeks Tibbi Urunler San. Ve Tic. Ltd. Sti. (Turkiye)

Main Activities: Surgical and Medical Instrument Manufacturing
Full name: Simeks Tibbi Urunler Sanayi Ve Ticaret Limited Sirketi Profile Updated: October 02, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Simeks Tibbi Urunler San. Ve Tic. Ltd. Sti. is a company based in Turkiye, with its head office in Istanbul. It operates in the Surgical and Medical Instrument Manufacturing sector. It was established on January 11, 1999. It currently has a total number of 44 (2024) employees. From the latest financial highlights, Simeks Tibbi Urunler San. Ve Tic. Ltd. Sti. reported a net sales revenue increase of 84.48% in 2022. A growth of 79.83% was recorded in its total assets. The net profit margin of Simeks Tibbi Urunler San. Ve Tic. Ltd. Sti. decreased by 14.91% in 2022.

Headquarters
Ist End Ve Tica Serb Bolg No:5 Aydinli Sb Mahallesi 10 Sokak Tuzla
Istanbul; Marmara; Postal Code: 34953

Contact Details: Purchase the Simeks Tibbi Urunler San. Ve Tic. Ltd. Sti. report to view the information.

Website: http://www.simeksmedical.com

Basic Information
Total Employees:
Purchase the Simeks Tibbi Urunler San. Ve Tic. Ltd. Sti. report to view the information.
Outstanding Shares:
Purchase the Simeks Tibbi Urunler San. Ve Tic. Ltd. Sti. report to view the information.
Incorporation Date:
January 11, 1999
Key Executives
Purchase this report to view the information.
Company Manager
Company Performance
Financial values in the chart are available after Simeks Tibbi Urunler San. Ve Tic. Ltd. Sti. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
84.48%
Total operating revenue
84.48%
Operating profit (EBIT)
112.46%
Net Profit (Loss) for the Period
63.56%
Total assets
79.83%
Total equity
75.59%
Operating Profit Margin (ROS)
7.49%
Net Profit Margin
-14.91%
Return on Equity (ROE)
-3.36%
Debt to Equity Ratio
-0.01%
Quick Ratio
-7.64%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?